PATENT CLAIM ANALYSIS

Application Number: 15949703
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "225200"]

Abstract:
The subject invention concerns materials and methods for treating depression, stress disorders, such as PTSD, anxiety disorders, and/or a neurodegenerative disease or condition in a person or animal. In one embodiment, a person or animal in need of treatment is administered one or more compounds or drugs, or a composition comprising the one or more compounds or drugs, that inhibit FKBP51 activity or function. The subject invention also concerns a method for inhibiting activity of the FKBP51 protein in a cell. The subject invention also concerns methods of screening for compounds or drugs that inhibit the FKBP51 protein.

Claim (Index 4):
The method according to  claim 1 , wherein the person or animal exhibits one or more single nucleotide polymorphisms (SNPs) in the FKBP5 gene, and wherein said one or more SNPs are associated with elevated levels of FKBP51 protein.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 91.0
- Lexical Diversity: 2.09615
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15209594', '14788364', '12994560', '15467867', '15655683']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7328157582614803
- 35 USC 102 Novelty (BERT): 0.547392431240117
- Combined Prediction Score: 0.7142734255593439
- Mean Citation Score: 238.789368
- Max Citation Score: 377.39816
- Similarity Product: 371.57226198102006

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test